Your session is about to expire
← Back to Search
Study Summary
This trial evaluated the safety and effectiveness of a new scar treatment compared to a placebo.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2021 Phase 1 & 2 trial • 22 Patients • NCT03880058Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have thick or keloid scars.I have a severe spine condition like scoliosis.I am not pregnant, breastfeeding, or if capable of becoming pregnant, I am using reliable birth control.I have a skin infection or rash on my back.I have been treated with SLI-F06 before.I am considered not suitable for surgery.I do not have conditions like diabetes or heart disease that could affect wound healing.I have a history of serious bleeding or clotting disorders.I have no significant health issues apart from my current condition.I am between 18 and 65 years old and in good health.I do not have active or uncontrolled skin conditions that could affect the study.My BMI is between 18.5 and 30, and I weigh at least 40 kg.Your shoulder blades are evenly spaced apart and at least 12 centimeters apart from each other.
- Group 1: Cohort A
- Group 2: Cohort B
- Group 3: Cohort C
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
What is the scope of recruitment for this research project?
"Affirmative. The information hosted on clinicaltrials.gov attests to the fact that this study is currently enrolling individuals for participation, with the original post being made July 25th 2022 and last revised August 24th 2022. For this trial, 30 guinea pigs are needed from a solitary medical centre."
Who is eligible to take part in this research project?
"This clinical trial is seeking 30 participants aged between 18 and 65 with wound healing conditions. To qualify, patients must meet these criteria."
What implications could SLI-F06 have on human health?
"Our team at Power has ranked the safety of SLI-F06 as a 2 since there is some evidence of its security, yet none indicating efficacy."
Are there available slots for individuals to become participants in this experiment?
"According to clinicaltrials.gov, this experiment is still recruiting individuals for participation. The protocol was first posted on July 25th 2022 and the most recent changes were made August 24th 2022."
Is the enrollment criteria for this trial inclusive of individuals aged 35 and over?
"According to the requirements of this trial, potential volunteers must be at least 18 years old and no older than 65."
Who else is applying?
What state do they live in?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger